Commission Implementing Decision (EU) 2025/953 of 23 May 2025 postponing the expiry date of the approval of medetomidine for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Text
Article-level text, parsed from the formex manifestation.
Article 1
The expiry date of the approval of medetomidine for use in biocidal products of product-type 21 set out in Implementing Decision (EU) 2022/1495 is postponed to 30 June 2026.
Article 2
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Relations
What this act cites, and what cites it.
Show relationsVersions
Point-in-time consolidated versions of this act.
Show versions